G 371 Pill - brown gray capsule/oblong, 23mm
Pill with imprint G 371 is Brown / Gray, Capsule/Oblong and has been identified as Topiramate Extended-Release 200 mg. It is supplied by Glenmark Pharmaceuticals Inc.
Topiramate is used in the treatment of Lennox-Gastaut Syndrome; Migraine Prevention; Seizures; Epilepsy; Seizure Prevention and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 371
Topiramate Extended-Release
- Imprint
- G 371
- Strength
- 200 mg
- Color
- Brown / Gray
- Size
- 23.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Pharmaceuticals Inc.
- National Drug Code (NDC)
- 68462-0371
Related images for "G 371"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,328)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Eprontia, Topiragen, Qudexy XR
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.